Oncocyte to Release First Quarter 2025 Results on May 12, 2025
Rhea-AI Summary
Oncocyte (Nasdaq: OCX), a diagnostics technology company, has scheduled its first quarter 2025 financial results announcement for May 12, 2025, after market close. The company will host a live Zoom webinar at 2:00 p.m. PT on the same day to discuss the results, followed by a Q&A session. Interested participants can access the webinar through registration, and a replay will be available on Oncocyte's investor relations website afterward.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, OCX gained 0.35%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
IRVINE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that it will report first quarter 2025 financial results after the market closes on Monday, May 12, 2025. Oncocyte will host a live Zoom webinar to discuss the company's financial results at 2:00 p.m. PT that same day.
The live webinar to discuss financial results, followed by Q&A, will be accessible via registration at the following link: Oncocyte Q1 2025 Earnings Webinar.
An archived replay will be available after the call concludes on Oncocyte’s investor relations website at https://investors.oncocyte.com.
About Oncocyte
Oncocyte is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. Investors may visit https://investors.oncocyte.com/ for more information.
Investor Contact:
Doug Farrell
LifeSci Advisors LLC
dfarrell@lifesciadvisors.com
FAQ
When will Oncocyte (OCX) release Q1 2025 earnings?
What time is Oncocyte's Q1 2025 earnings call?
How can I access Oncocyte's Q1 2025 earnings call?
Where can I find the replay of Oncocyte's Q1 2025 earnings call?
